Metabolon Files Patent Infringement Lawsuit against Stemina
News Aug 28, 2012
Metabolon, Inc., has filed a patent infringement lawsuit against Stemina Biomarker Discovery, Inc. in the US District Court for the Western District of Wisconsin.
The lawsuit seeks a ruling that Stemina’s services directly infringe on US Patent 7,550,258 and US Patent 7,910,301 which relate to global analysis of complex biological samples for the discovery of biomarkers and pathways associated with drug action, toxicity and disease.
Comments | 0 ADD COMMENT
Decoding Microbial Metabolism Explains Biofuel Yield
News Jan 20, 2017
Protein Discovered that Protects Against Fatty Liver
News Jan 18, 2017